Aurobindo Pharma will make panic disorder drug in US
Drug firm Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market tablets of Alprazolam, a central nervous system drug, in the American market.
June 09, 2011 / 12:43 IST
Drug firm Aurobindo Pharma today said it has received final approval from the US health regulator to manufacture and market tablets of Alprazolam, a central nervous system drug, in the American market.
The company has received final approval from the US Food and Drug Administration (USFDA) to manufacture and market Alprazolam extended-release tablets in strengths of 0.5 mg, 1 mg, 2 mg and 3mg, Aurobindo Pharma said in a filing to the Bombay Stock Exchange (BSE)."The product has a market size of approximately USD26.5 million for the twelve months ending September, 2010, according to IMS and will be launched soon," the company added.Alprazolam extended-release tablets are the generic equivalent of Xanax XR tablets. The tablets are indicated for treating panic disorders and fall under the central nervous system (CNS) segment, it said.The Hyderabad-based firm now has a total of 137 ANDA approvals from the USFDA, it added. Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
